The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

19 Dec 2022 15:44

RNS Number : 2176K
DeepMatter Group PLC
19 December 2022
 

19 December 2022

 

DeepMatter Group Plc

("DeepMatter", the "Company" or the "Group")

 

Results of General Meeting

 

DeepMatter Group Plc (AIM: DMTR), the international digital chemistry data and software company, announces that, at the general meeting of the Company held earlier today all resolutions proposed (the "Resolutions") were duly passed. The Resolutions included the special resolutions in respect of the proposed cancellation of the admission of the Company's ordinary shares to trading on AIM (the "Cancellation"), the re-registration of the Company as a private limited company (the "Re-registration") and the adoption of new articles of association.

 

As set out in the circular posted to shareholders of 02 December 2022 (the "Circular"), the Cancellation will become effective on 05 January 2023 and it is expected that the Re-registration will occur in the week commencing 16 January 2023. Shareholders are reminded that the last day of dealings in Deepmatter ordinary shares on AIM will be 04 January 2023.

 

Details of the number of proxy votes cast for, against and withheld in respect of the resolutions are set out below:

 

Resolution

Votes For (Including Discretionary)

Votes Against

Total Number of Votes Made (excluding Withheld)

Votes Withheld

No. of shares

% of shares voted

No. of shares

% of shares voted

No. of shares

% of issued share capital

No. of shares

1.

Special Resolution - To approve the Cancellation

1,778,868,488

97.6%

43,422,199

 

2.4%

 

1,822,290,687

 

45.2%

 

8,254

 

2.

Special Resolution - Subject to Resolution 1 becoming effective, (i) to approve the Re-registration and (ii) to approve and adopt the new articles of association

1,778,868,488

 

97.6%

43,422,199

 

2.4%

 

1,822,290,687

 

45.2%

 

8,254

 

3.

Ordinary Resolution - In connection with the proposed Subscription, the Directors' authority to allot shares up to an aggregate nominal amount of £250,000

1,779,331,914

 

97.6%

42,871,067

 

2.4%

 

1,822,202,981

 

45.2%

 

95,960

 

4.

Special Resolution - Subject to Resolution 3 becoming effective, the Directors be empowered to allot equity securities in connection with the proposed Subscription

1,779,181,880

 

97.6%

43,030,593

 

2.4%

 

1,822,212,473

 

45.2%

 

86,468

 

5.

Ordinary Resolution - Subject to Resolutions 3 and 4 becoming effective, the Directors be authorised to restate the share option pool

1,778,385,246

 

97.6%

43,428,765

 

2.4%

 

1,821,814,011

 

45.2%

 

484,930

 

6.

Ordinary Resolution - Subject to Resolutions 3 and 4 becoming effective, the Directors be authorised to exercise all the powers of the Company to allot and make offers to allot Relevant Securities up to an aggregate nominal amount of £130,665

1,779,295,393

 

97.6%

42,921,067

 

2.4%

 

1,822,216,460

 

45.2%

 

82,481

 

7.

Special Resolution - Subject to Resolutions 3,4 and 6 becoming effective, the Directors be empowered to allot equity securities up to a maximum nominal amount of £130,665

1,778,578,203

 

97.6%

43,524,744

 

2.4%

 

1,822,102,947

 

45.2%

 

195,994

 

 

Matched Bargain Facility

 

The Directors are aware that Shareholders may wish to acquire or dispose of Ordinary Shares in the Company following the Cancellation. The Company has concluded that it will put in place a matched bargain facility and intends to appoint Asset Match (www.assetmatch.com) to facilitate trading in the Ordinary Shares on a matched bargain basis following Cancellation ("Matched Bargain Facility"). Asset Match, a firm authorised and regulated by the Financial Conduct Authority, will operate an electronic off-market dealing facility for the Ordinary Shares. This facility will allow Shareholders and new investors to trade Ordinary Shares by matching buyers and sellers through periodic auctions. Investors can register their interest for further information on the Asset Match auction process by emailing dealing@assetmatch.com.

 

Expected Timetable of Principal Events (as previously announcement on 01 December 2022)

 

Event

Time and/or date(1)(2)

Last day of dealings in Ordinary Shares on AIM

4 January 2022

Cancellation

5 January 2023

Allotment and issue of the Non-VCT/EIS Subscription Shares

5 January 2023

Allotment and issue of the VCT/EIS Subscription Shares

6 January 2023

Despatch of definitive share certificates in respect of the Subscription Shares

6 January 2023

Re-registration as a private company

Week commencing 16 January 2023

Capitalised terms used but not defined in this announcement shall have the meaning given to them in the Circular posted on 02 December 2022 which is available on the Company's website at deepmatter.io/investors

 

For more information contact

 

DeepMatter Group Plc

Mark Warne, Chief Executive 0141 548 8156

Fraser Benson, Chief Financial Officer

Canaccord Genuity Limited (Nominated Adviser and Broker) Bobbie Hilliam 020 7523 8000

Meare Consulting Adrian Duffield 07990 858548

About DeepMatter Group plc 

 

DeepMatter's SmartChemistry® platform enables scientists across a range of industries, including pharma, biotech, agri-science, scientific publishers and contract research organisations (CROs), to easily capture, access and exploit the vast amounts of data created in chemical reactions.

 

DeepMatter integrates its proprietary chemistry data and proprietary software to significantly improve productivity, efficiency, discovery, safety and sustainability of chemical reactions for its customers.

 

DeepMatter's SmartChemistry® platform capitalises on the combination of its cloud technology, low cost-sensors, connectivity to laboratory hardware and high-performance computing trends such as artificial intelligence (AI).

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

Prior to this announcement's release, the statement contained inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR) (Market Abuse Regulation).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMEKLFFLLLXFBD
Date   Source Headline
22nd Mar 201910:39 amRNSHolding(s) in Company
20th Mar 20197:00 amRNSDirectors' Shareholdings
19th Mar 20194:52 pmRNSReplacement - Total Voting Rights and Notice of...
19th Mar 20193:35 pmRNSHolding(s) in Company
19th Mar 20193:32 pmRNSHolding(s) in Company
15th Mar 20198:10 amRNSTotal Voting Rights and Notice of Results
12th Mar 20197:00 amRNSGrant of Options
11th Mar 201912:58 pmRNSResult of Meeting & Directorate Change
7th Mar 20199:00 amRNSIssue of Equity
25th Feb 20197:00 amRNSAcquisition, Placing & Waiver of Rule 9
14th Feb 20193:58 pmRNSHolding(s) in Company
6th Feb 20194:42 pmRNSHolding(s) in Company
6th Feb 20194:41 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSDisposal of SICM business
20th Dec 20187:00 amRNSUpdate, Conditional Acquisition & Proposed Placing
30th Nov 20187:00 amRNSPublication of Paper in leading Journal
6th Sep 20183:06 pmRNSExercise of Options and Issue of Equity
6th Sep 20187:00 amRNSInterim Results
15th Aug 20187:00 amRNSFurther Pioneer Agreements and Notice of Results
19th Jul 20187:00 amRNSPublication of Scientific Paper
11th Jun 20187:00 amRNSDirectorate Changes
11th Jun 20187:00 amRNSIssue of Equity
16th May 201811:45 amRNSResult of AGM, name change and new website
24th Apr 20187:00 amRNSDirector Dealing
19th Apr 20187:00 amRNSSecond Pioneer Agreement Signed
12th Apr 20187:00 amRNSFirst Pioneer Agreement Signed
5th Apr 20183:28 pmRNSDirector Dealing
28th Mar 20187:00 amRNSFinal results for the year ended 31 December 2017
6th Feb 20187:00 amRNSMoUs signed with pioneers
19th Jan 20189:00 amRNSPublication of Scientific Paper
17th Jan 20187:00 amRNSPublication of Scientific Paper
6th Dec 20177:00 amRNSDirector Dealing
4th Dec 20177:00 amRNSNew Share Option Scheme and Grant to PDMR
1st Dec 20171:01 pmRNSDirectors' Dealing
28th Nov 20179:47 amRNSDirector Dealing
22nd Nov 20175:50 pmRNSHolding(s) in Company
20th Nov 201711:02 amRNSHolding(s) in Company
8th Nov 20178:11 amRNSCompletion of Acquisition, Appointment of Director
3rd Nov 20177:00 amRNSAcquisition of OpenIOLabs Limited
4th Oct 20177:00 amRNSChange of Adviser
12th Sep 20177:00 amRNSHalf-year Report
19th May 201711:34 amRNSResult of AGM
26th Apr 20177:00 amRNSDirectorate Changes
28th Mar 20177:00 amRNSFinal Results
16th Feb 20177:00 amRNSDigital Chemistry to be performed in space
31st Jan 20178:03 amRNSAdvisory Committee
31st Jan 20177:00 amRNSPresentation at Healthcare Conference
9th Jan 20177:00 amRNSDigitalGlasswareT
15th Sep 20167:00 amRNSHalf-year Report
12th May 201611:45 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.